DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Celgene (NASDAQ: CELG)



company name or ticker

Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks

Cramer -- Be Careful Buying GrubHub, Biogen Is a Battleground

Short Sellers Back Off Major Biotechs

FCX, CLF, BIIB, COF: Jim Cramer's Views

1 ETF That’s Crushing Even Warren Buffett

Warren Buffett's Berkshire Hathaway has rarely been beaten by any fund for lengthy periods of time. But this ETF is doing it in spades. Here's how.

Biotech IPO Boom Gaining Thrust With NantKwest Debut

Seeking Alpha's Biotech Weekly: What Can Biogen Tell Us About The Sector?

Cramer: Biogen's Horseman May Have Fallen Off, But These 3 Are Better

Celgene Delivers as Expected in Q2, but Raises New Questions

Celgene once again trounces Wall Street's expectations in the second quarter, but this earnings report also came with a few surprises.

Wall Street Mixed On Biogen Before Earnings